课题基金 / 基金详情

项目摘要

项目成果

Guangchun Bai的其他基金

相似基金

相关文献

中文摘要
翻译
我们选择代理研究计划的核心是ABSL3/BSL3/NIHBL3设施。目的 ABSL3/BSL3/NIHBL3核心(核心B)的目的是提供高质量、统一的方济氏菌来源 Tularens(Ft),避免重复工作,为所有调查人员提供共享资源。其基本原理是 由训练有素的技术人员运营的中央设施将最能够始终如一地产生可靠的 本计划项目所有组成部分的试剂。核心B的主要目标是确保适当的 维护和供应细菌种群;提供ABSL3畜牧业和维护 ABSL3/BSL3/NIHBL3设施;并为在该套房工作的个人提供培训和监督。至 要实现这些目标,核心B将: 1.维护Ft SchuS4股票文化。 2.提供畜牧业和BSL3设施维护。 3.提供培训和监督。
英文摘要
Central to the efforts of our Select Agent research program is the ABSL3/BSL3/NIHBL3 facility. The purpose of the ABSL3/BSL3/NIHBL3 core (Core B) is to provide a high quality, uniform source of Francisella tularensis (Ft), avoid duplication of work, and provide a shared resource for all investigators. The rationale is that a centralized facility run by trained technicians will be best able to consistently generate reliable reagents for all components of the Program Project. The primary objectives of Core B are to ensure proper maintenance and supply of bacterial stocks; to provide ABSL3 animal husbandry and maintenance of the ABSL3/BSL3/NIHBL3 facility; and to provide training and oversight to individuals working in the suite. To achieve these goals, Core B will: 1. Maintain Ft SchuS4 stock cultures. 2. Provide animal husbandry and BSL3 facility maintenance. 3. Provide training and oversight.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel c-di-AMP-based recombinant BCG vaccine
  • 批准号:
    10667007
  • 项目类别:
  • 资助金额:
    $24.45万
  • 财政年份:
    2023
  • 负责人:
    Guangchun Bai
  • 依托单位:
Microbiology Core
  • 批准号:
    8698577
  • 项目类别:
  • 资助金额:
    $27.79万
  • 财政年份:
    --
  • 负责人:
    Guangchun Bai
  • 依托单位:
Microbiology Core
  • 批准号:
    9103001
  • 项目类别:
  • 资助金额:
    $25.88万
  • 财政年份:
    --
  • 负责人:
    Guangchun Bai
  • 依托单位:
海外基金